Font Size: a A A

The Development Strategy Analysis After The Asset Restructuring Of HPGC Based On The Harvard Analysis Framewrok

Posted on:2019-05-13Degree:MasterType:Thesis
Country:ChinaCandidate:Q M LiFull Text:PDF
GTID:2429330563997888Subject:Accounting master
Abstract/Summary:PDF Full Text Request
Under the background of rapid economic development and the continuous introduction of supportive policies,China's pharmaceutical industry has entered a new stage of development.As the life industry which concerns the health of our people,the medical economy of our country has been growing at a high speed.At the same time,the competitiveness of the pharmaceutical industry in China is increasing,and the problems encountered in the development process of pharmaceutical enterprises and the research on the solutions have become the subjects that scholars attach importance to.As the first successful listed pharmaceutical company in China,Harbin pharmaceutical co.,ltd.has been widely concerned by all sectors of society.With the continuous upgrading of enterprises' development measures and competition means,the way of asset reorganization is also applied to various enterprises.Reasonable and effective asset reorganization can optimize enterprise resource allocation,promote the enterprise economic operation efficiency,and improve the corporate governance structure.The business activities and financial situation of Harbin pharmaceutical company from 2010 to 2016 have been comprehensively analyzed through the Harvard Framework.The key observation points are 2011 and 2015 years.In these two years.What impact will be appeared with the Harbin pharmaceutical group shares the assets reorganization among the two subjects twice with the Sanchine pharmaceutical group and whether the assets reorganization will be the “cardiac stimulant” of the enterprise resources.The first step through strategic analysis can fully understand that the pharmaceutical industry is in a competitive stage.Then,It can be found that Harbin pharmaceutical group didn't use the relevant approach to whitewash the financial situation and the corresponding fluctuations also conforms to the economic background and the actual situation of the company by analyzing the quality of specific projects and identifying key fiscal policies and fiscal estimates.After this step,analyzing the finance and using the data from the annual report of the three ability in enterprise and cash flow analysis in nearly seven years.It could intuitive understanding that whether the two reorganization brings positive impact and find the related problems for the enterprise and puts forward countermeasures.Finally,it will make a prediction on the sales,profit,expense and risk of the enterprise.It based on the analysis of these three steps and will put forward the final development strategy.
Keywords/Search Tags:Financial Analysis, Harvard Framework, Pharmaceutical Enterprise, Asset Restructuring
PDF Full Text Request
Related items